These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 3144166

  • 1. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH, Kunze KP, Schlüter M, Duckeck W.
    Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166
    [Abstract] [Full Text] [Related]

  • 2. Effect of encainide and flecainide on chronic ectopic atrial tachycardia.
    Kunze KP, Kuck KH, Schlüter M, Bleifeld W.
    J Am Coll Cardiol; 1986 May 20; 7(5):1121-6. PubMed ID: 3082957
    [Abstract] [Full Text] [Related]

  • 3. Encainide for resistant supraventricular tachycardia in children: follow-up report.
    Strasburger JF, Smith RT, Moak JP, Gothing C, Garson A.
    Am J Cardiol; 1988 Dec 20; 62(19):50L-54L. PubMed ID: 3144168
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 5. Treatment of ectopic atrial arrhythmias and premature atrial complexes in adults with encainide.
    Pool PE, Quart BD.
    Am J Cardiol; 1988 Dec 20; 62(19):60L-62L. PubMed ID: 2462340
    [Abstract] [Full Text] [Related]

  • 6. Successful use of an intravenous infusion of flecainide and amiodarone for a refractory combination of postoperative junctional and ectopic tachycardias.
    Haas NA, Fox S, Skinner JR.
    Cardiol Young; 2005 Aug 20; 15(4):427-30. PubMed ID: 16014194
    [Abstract] [Full Text] [Related]

  • 7. Suppression of incessant supraventricular tachycardia by intravenous and oral encainide.
    Brugada P, Abdollah H, Wellens HJ.
    J Am Coll Cardiol; 1984 Dec 20; 4(6):1255-60. PubMed ID: 6438205
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 9. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA, Kuhn RJ, McCaffrey FM.
    Ann Pharmacother; 1997 Nov 25; 31(11):1347-59. PubMed ID: 9391691
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of incessant supraventricular tachycardia treated with oral encainide.
    Brugada P, Wellens HJ.
    Eur Heart J; 1987 Apr 25; 8(4):369-71. PubMed ID: 3111853
    [Abstract] [Full Text] [Related]

  • 12. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
    Fish FA, Gillette PC, Benson DW.
    J Am Coll Cardiol; 1991 Aug 25; 18(2):356-65. PubMed ID: 1906902
    [Abstract] [Full Text] [Related]

  • 13. Flecainide and encainide.
    Furlanello F, Vergara G, Bettini R, Mosna G, Gramegna L, Disertori M.
    Eur Heart J; 1987 Mar 25; 8 Suppl A():33-40. PubMed ID: 3107989
    [Abstract] [Full Text] [Related]

  • 14. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs.
    Feld GK, Chen PS, Nicod P, Fleck RP, Meyer D.
    Am J Cardiol; 1990 Aug 01; 66(3):378-83. PubMed ID: 2114784
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia.
    Akhtar M, Niazi I, Naccarelli GV, Tchou P, Rinkenberger R, Dougherty AH, Jazayeri M.
    Am J Cardiol; 1988 Dec 20; 62(19):45L-49L. PubMed ID: 3144167
    [Abstract] [Full Text] [Related]

  • 17. Encainide versus flecainide in the treatment of chronic resistant paroxysmal atrial tachyarrhythmias.
    Coumel P.
    Cardiovasc Drugs Ther; 1990 Jun 20; 4 Suppl 3():579-84. PubMed ID: 2125836
    [Abstract] [Full Text] [Related]

  • 18. Encainide and flecainide: are they interchangeable?
    Saini V, Podrid PJ, Slater W, Lown B.
    Am Heart J; 1989 Jun 20; 117(6):1253-8. PubMed ID: 2499169
    [Abstract] [Full Text] [Related]

  • 19. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
    Myerburg RJ, Kessler KM, Cox MM, Huikuri H, Terracall E, Interian A, Fernandez P, Castellanos A.
    Circulation; 1989 Dec 20; 80(6):1571-9. PubMed ID: 2480856
    [Abstract] [Full Text] [Related]

  • 20. Electrophysiology in assessing supraventricular arrhythmias: value of programmed stimulation in predicting and understanding efficacy of encainide.
    Wellens HJ, Brugada P.
    Am J Cardiol; 1986 Aug 29; 58(5):37C-40C. PubMed ID: 3092617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.